temozolomide has been researched along with dimethyl sulfoxide in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Braun, K; Kliem, C; Pipkorn, R; Waldeck, W; Wiessler, M | 1 |
Dharmalingam, K; Kumar, DM; Nila, MV; Patil, V; Ramachandran, B; Somasundaram, K | 1 |
Day, EK; Lazzara, MJ; Purow, B; Zhong, Q | 1 |
4 other study(ies) available for temozolomide and dimethyl sulfoxide
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The Diels-Alder-reaction with inverse-electron-demand, a very efficient versatile click-reaction concept for proper ligation of variable molecular partners.
Topics: Chloroform; Dacarbazine; Deuterium; Dimethyl Sulfoxide; Magnetic Resonance Spectroscopy; Molecular Structure; Organic Chemicals; Organic Chemistry Phenomena; Peptides; Solvents; Temozolomide | 2009 |
Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity.
Topics: Antineoplastic Agents, Alkylating; Blotting, Western; Cell Line, Tumor; Cell Survival; Cluster Analysis; Dacarbazine; Dimethyl Sulfoxide; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Glioma; Humans; Interleukin-1 Receptor-Associated Kinases; NF-kappa B; Proteome; Real-Time Polymerase Chain Reaction; Reproducibility of Results; RNA, Small Interfering; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Temozolomide; Toll-Like Receptors | 2013 |
Data-Driven Computational Modeling Identifies Determinants of Glioblastoma Response to SHP2 Inhibition.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Data Science; Dimethyl Sulfoxide; DNA Repair; Drug Resistance, Neoplasm; Female; Gefitinib; Glioblastoma; Heterografts; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Least-Squares Analysis; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, SCID; Models, Biological; Neoplasm Transplantation; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Ribonucleoproteins, Small Nuclear; Signal Transduction; src Homology Domains; Sulfones; Temozolomide; Transcription Factor AP-1 | 2021 |